Literature DB >> 17646730

Cushing's syndrome patient who exhibited congestive heart failure.

L Petramala1, P Battisti, G Lauri, L Palleschi, D Cotesta, M Iorio, G De Toma, S Sciomer, C Letizia.   

Abstract

Cushing's Syndrome (CS) may sometimes lead to dilated cardiomyopathy, even though this condition can be partially or completely reversed after treatment. In this article we report the case of a 28-yr-old woman with CS secondary to adrenal adenoma who exhibited congestive heart failure as an initial symptom. Two weeks before being admitted to our hospital, the patient started complaining of shortness of breath, orthopnea, paroxysmal nocturnal dyspnea and generalized edema. A physical examination did not reveal signs of hypercortisolism. Chest auscultation revealed bilateral diffused crepitation; blood pressure was 180/120 mmHg with heart rate of 90 beats/min. A chest X-ray showed a cardiac shade enlargement due to congestive heart failure. Transthoracic echocardiography demonstrated a dilated left ventricle and an impaired left ventricular systolic function. The patient's urinary cortisol excretion was elevated and circadian rhythm of cortisol was absent. ACTH level was low. In addition, plasma cortisol failed to decrease after administration of dexamethasone. An abdominal magnetic resonance imaging scan showed a 7-cm right adrenal mass. The patient was administered oxygen, spironolactone, ACE-inhibitor and the signs and symptoms of heart failure gradually improved. A laparoscopic right adrenalectomy was performed and pathological examination of the gland showed a benign adrenocortical adenoma. After the adrenalectomy the patient was started on hydrocortisone therapy and 5 months later the wall thickness of the left ventricle was within normal range and the patient's blood pressure was 130/80 mmHg. In conclusion we report the case of heart failure as the main clinical symptom in CS secondary to adrenal adenoma.

Entities:  

Mesh:

Year:  2007        PMID: 17646730     DOI: 10.1007/BF03346339

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

Review 1.  Cushing's syndrome.

Authors:  M Boscaro; L Barzon; F Fallo; N Sonino
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

Review 2.  Diagnosis and complications of Cushing's syndrome: a consensus statement.

Authors:  G Arnaldi; A Angeli; A B Atkinson; X Bertagna; F Cavagnini; G P Chrousos; G A Fava; J W Findling; R C Gaillard; A B Grossman; B Kola; A Lacroix; T Mancini; F Mantero; J Newell-Price; L K Nieman; N Sonino; M L Vance; A Giustina; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

3.  The hypercalcemia of adrenal insufficiency.

Authors:  M WALSER; B H ROBINSON; J W DUCKETT
Journal:  J Clin Invest       Date:  1963-04       Impact factor: 14.808

Review 4.  Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.

Authors:  Catherine Beauregard; Gabriel Dickstein; André Lacroix
Journal:  Treat Endocrinol       Date:  2002

Review 5.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

Authors:  J Newell-Price; P Trainer; M Besser; A Grossman
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

Review 6.  Pathophysiology of heart failure following myocardial infarction.

Authors:  A D Struthers
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

7.  Etiology of hypercalcemia in a patient with Addison's disease.

Authors:  E Muls; R Bouillon; J Boelaert; G Lamberigts; S Van Imschoot; R Daneels; P De Moor
Journal:  Calcif Tissue Int       Date:  1982       Impact factor: 4.333

8.  Cushing's syndrome: still a potential killing disease.

Authors:  P A Younge; D Shmidt; P G Wiles
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

9.  Disproportionate hypertrophy of the interventricular septum and its regression in Cushing's syndrome. Report of three cases.

Authors:  N Sugihara; M Shimizu; K Shimizu; H Ino; I Miyamori; H Nakabayashi; R Takeda
Journal:  Intern Med       Date:  1992-03       Impact factor: 1.271

10.  Cardiac characteristics and postoperative courses in Cushing's syndrome.

Authors:  N Sugihara; M Shimizu; Y Kita; K Shimizu; H Ino; I Miyamori; H Nakabayashi; R Takeda
Journal:  Am J Cardiol       Date:  1992-06-01       Impact factor: 2.778

View more
  6 in total

1.  Reversible cushing dilated cardiomyopathy mimicking peripartum cardiomyopathy with successful subsequent pregnancy.

Authors:  Rashed Al Banna; Aysha Husain; Jalila Al Aali; Khalid Ebrahim; Abdulaziz Mohammed
Journal:  BMJ Case Rep       Date:  2011-11-08

2.  An unusual cause of reversible cardiomyopathy.

Authors:  Philip C Johnston; A Brew Atkinson; Michael J Moore; Divyesh Sharma; Neil R Black; Lana J Dixon; John R Lindsay
Journal:  Ulster Med J       Date:  2012-09

3.  A Case of Acute Aortic Dissection Type B Associated with Cushing's Syndrome.

Authors:  Luigi Petramala; Dario Cotesta; Paolo Sapienza; Laura Zinnamosca; Enrico Moroni; Luca di Marzio; Giorgio De Toma; Claudio Letizia
Journal:  J Clin Med Res       Date:  2009-03-24

4.  Glucocorticoid Receptor-Binding and Transcriptome Signature in Cardiomyocytes.

Authors:  Elena Severinova; Saleena Alikunju; Wei Deng; Puneet Dhawan; Nazish Sayed; Danish Sayed
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

Review 5.  Onset of Aortic Dissection Complicated with Cushing's Disease: A Case Report and Review of the Literature.

Authors:  Haruka Takenouchi; Takatoshi Anno; Hideyuki Iwamoto; Kaio Takahashi; Yuichiro Iwamoto; Megumi Horiya; Yukiko Kimura; Fumiko Kawasaki; Kohei Kaku; Koichi Tomoda; Shigeki Ono; Hideaki Kaneto
Journal:  Intern Med       Date:  2022-07-15       Impact factor: 1.282

Review 6.  Dilated Cardiomyopathy Revealing Cushing Disease: A Case Report and Literature Review.

Authors:  Lucien Marchand; Bérénice Segrestin; Marion Lapoirie; Véronique Favrel; Julie Dementhon; Emmanuel Jouanneau; Gérald Raverot
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.